Related Experiment Video

Updated: Jun 14, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

NF-kappaB and STAT3 signaling in glioma: targets for future therapies

George P Atkinson1, Susan E Nozell, Etty Tika N Benveniste

  • 1Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA.

Expert Review of Neurotherapeutics
|April 7, 2010
PubMed

Insights

Glioblastoma, a challenging brain tumor, is driven by aberrant NF-kappaB and JAK/STAT signaling pathways. New therapies aim to target these oncopathways for improved glioblastoma survival.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Cancer signaling pathways

Background:

  • Glioblastoma (GBM) presents significant therapeutic challenges with limited survival improvements over five decades.
  • Aberrant intracellular signaling pathways are key drivers of GBM tumor phenotype and progression.

Purpose of the Study:

  • To review the fundamental mechanisms of the NF-kappaB and JAK/STAT signaling pathways.
  • To elucidate the specific roles of NF-kappaB and JAK/STAT signaling in glioblastoma pathogenesis.
  • To explore emerging therapeutic strategies targeting these pathways in GBM treatment.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of high-throughput screening data.
  • Synthesis of current knowledge on NF-kappaB and JAK/STAT signaling in GBM.

Main Results:

  • NF-kappaB and JAK/STAT pathways are frequently dysregulated in glioblastoma.
  • These pathways contribute to glioblastoma proliferation, survival, and therapeutic resistance.
  • Experimental compounds targeting these pathways show promise in preclinical models.

Conclusions:

  • Targeting NF-kappaB and JAK/STAT signaling represents a promising therapeutic avenue for glioblastoma.
  • Integrating knowledge of these pathways into existing treatment regimens may improve patient outcomes.
  • Further research is warranted to translate these findings into clinical practice.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...